Oncocyte Corporation - Common Shares, No Par Value (OCX)

CUSIP: 68235C107

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Shares, No Par Value
Shares outstanding
28,495,649
Total 13F shares
31,284,691
Share change
-1,856,958
Total reported value
$43,477,422
Price per share
$1.39
Number of holders
55
Value change
-$4,537,534
Number of buys
30
Number of sells
26

Quarterly Holders Quick Answers

What is CUSIP 68235C107?
CUSIP 68235C107 identifies OCX - Oncocyte Corporation - Common Shares, No Par Value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BROADWOOD CAPITAL INC
13F
Company
52%
14,716,204
$28,108,000 30 Jun 2020
13F
PURA VIDA INVESTMENTS, LLC
13F
Company
21%
5,983,724
$11,429,000 30 Jun 2020
13F
Blackcrane Capital, LLC
13F
Company
10%
2,982,557
$5,697,000 30 Jun 2020
13F
BlackRock Finance, Inc.
13F
Company
9.1%
2,598,615
$4,964,000 30 Jun 2020
13F
VANGUARD GROUP INC
13F
Company
6.4%
1,813,492
$3,464,000 30 Jun 2020
13F
STATE STREET CORP
13F
Company
2.2%
624,652
$1,193,000 30 Jun 2020
13F
NORTHERN TRUST CORP
13F
Company
1.7%
494,032
$944,000 30 Jun 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
477,589
$912,000 30 Jun 2020
13F
Phoenix Financial Ltd.
13F
Company
1%
292,275
$597,000 30 Jun 2020
13F
Nuveen Asset Management, LLC
13F
Company
0.98%
280,515
$536,000 30 Jun 2020
13F
ETF MANAGERS GROUP, LLC
13F
Company
0.51%
145,650
$470,000 30 Jun 2020
13F
Informed Momentum Co LLC
13F
Company
0.85%
241,769
$462,000 30 Jun 2020
13F
Penbrook Management LLC
13F
Company
0.76%
215,625
$412,000 30 Jun 2020
13F
P.A.W. CAPITAL CORP
13F
Company
0.7%
200,000
$382,000 30 Jun 2020
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.67%
189,649
$362,000 30 Jun 2020
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.54%
155,300
$297,000 30 Jun 2020
13F
Private Wealth Partners, LLC
13F
Company
0.53%
150,000
$287,000 30 Jun 2020
13F
Bank Julius Baer & Co. Ltd, Zurich
13F
Company
0.53%
150,000
$286,000 30 Jun 2020
13F
BARCLAYS PLC
13F
Company
0.43%
123,841
$237,000 30 Jun 2020
13F
Bank of New York Mellon Corp
13F
Company
0.41%
117,479
$224,000 30 Jun 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.36%
102,611
$196,000 30 Jun 2020
13F
Mesirow Financial Investment Management, Inc.
13F
Company
0.35%
99,282
$190,000 30 Jun 2020
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.26%
74,700
$143,000 30 Jun 2020
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.24%
68,575
$131,000 30 Jun 2020
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.23%
65,227
$125,000 30 Jun 2020
13F
JANE STREET GROUP, LLC
13F
Company
0.18%
51,367
$98,000 30 Jun 2020
13F
MORGAN STANLEY
13F
Company
0.18%
50,144
$96,000 30 Jun 2020
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.17%
49,857
$96,000 30 Jun 2020
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.1%
27,819
$90,000 30 Jun 2020
13F
UBS Group AG
13F
Company
0.15%
43,885
$83,000 30 Jun 2020
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.15%
43,100
$82,000 30 Jun 2020
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.14%
39,400
$75,000 30 Jun 2020
13F
RHUMBLINE ADVISERS
13F
Company
0.13%
37,098
$71,000 30 Jun 2020
13F
JPMORGAN CHASE & CO
13F
Company
0.13%
36,850
$71,000 30 Jun 2020
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
35,627
$68,000 30 Jun 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
31,367
$60,000 30 Jun 2020
13F
Virtu Financial LLC
13F
Company
0.09%
26,504
$51,000 30 Jun 2020
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.09%
26,457
$51,000 30 Jun 2020
13F
SG Americas Securities, LLC
13F
Company
0.08%
23,539
$45,000 30 Jun 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.08%
22,900
$44,000 30 Jun 2020
13F
DEUTSCHE BANK AG\
13F
Company
0.08%
22,207
$42,000 30 Jun 2020
13F
Squarepoint Ops LLC
13F
Company
0.08%
21,377
$41,000 30 Jun 2020
13F
VAN ECK ASSOCIATES CORP
13F
Company
0.06%
17,205
$33,000 30 Jun 2020
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.05%
15,418
$29,000 30 Jun 2020
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.05%
15,387
$29,000 30 Jun 2020
13F
Williams Jones Wealth Management, LLC.
13F
Company
0.05%
15,000
$29,000 30 Jun 2020
13F
Arete Wealth Advisors, LLC
13F
Company
0.04%
12,500
$24,000 30 Jun 2020
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.04%
10,175
$19,000 30 Jun 2020
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.03%
9,863
$19,000 30 Jun 2020
13F
Tower Research Capital LLC (TRC)
13F
Company
0.03%
8,603
$17,000 30 Jun 2020
13F

Institutional Holders of Oncocyte Corporation - Common Shares, No Par Value (OCX) as of Q3 2020

As of 30 Sep 2020, Oncocyte Corporation - Common Shares, No Par Value (OCX) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,284,691 shares. The largest 10 holders included BROADWOOD CAPITAL INC, PURA VIDA INVESTMENTS, LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, Phoenix Holdings Ltd., Bank Julius Baer & Co. Ltd, Zurich, and BRIDGEWAY CAPITAL MANAGEMENT INC. This page lists 55 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2020 vs Q2 2020 Across Filers

Q2 2020 holders
57
Q3 2020 holders
55
Holder diff
-2
Investor Q2 2020 Shares Q3 2020 Shares Share Diff Share Chg % Q2 2020 Value $ Q3 2020 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .